COMMUNIQUÉS West-GlobeNewswire

Teewinot Life Sciences Announces Executive Leadership Changes
22/05/2019
New management team brings decades of experience in leadership and operational management of drug development and manufacturing, including the financial transition of companies from private to public markets TAMPA, Fla [...]
Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress
22/05/2019
- Company to focus on the development of AFM13, AFM24 and preclinical innate cell engagers, decides to terminate AFM11 T cell engager Phase 1 program - - Received milestone payment from Genentech, continuing to [...]
Mois de l’activité physique
22/05/2019
Des risques majeurs pour la santé liés à la sédentarité MONTRÉAL, 22 mai 2019 (GLOBE NEWSWIRE) -- Dans le cadre du mois de l’activité physique , la Fondation de l’Institut de Cardiologie de Montréal fait le point sur la [...]
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
22/05/2019
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397, which covers the high [...]
Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update
22/05/2019
Top-line results from Phase III Epsolay ® and TWIN trials remain on track; mid-2019 and 4Q19, respectfully Reports top-line generic product revenues of $6.3 million NESS ZIONA, Israel, May 22, 2019 (GLOBE NEWSWIRE) -- [...]
Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
22/05/2019
FDA Assigns Prescription Drug User Fee Act (PDUFA) Goal Date of November 16, 2019 PRINCETON, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today announced [...]
BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment
22/05/2019
More than 260 participants have been enrolled to the study JERUSALEM, Israel and HACKENSACK, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”) today announced it reached [...]
Nabriva Therapeutics to Present at the Jefferies 2019 Healthcare Conference
22/05/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 22, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]
Emerald Health Therapeutics Appoints Chief Operating Officer
22/05/2019
Sean Rathbone brings extensive expertise in capital projects, operational leadership and corporate process management VICTORIA, British Columbia, May 22, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (" [...]
HEXO strengthens leadership team, appoints Donald Courtney as Chief Operating Officer
22/05/2019
GATINEAU, Quebec, May 22, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is further strengthening its leadership team by appointing Donald Courtney as Chief Operating Officer. “I [...]
HEXO renforce son équipe de direction et nomme Donald Courtney au poste de directeur principal de l’exploitation
22/05/2019
GATINEAU, Québec, 22 mai 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE-A : HEXO) renforce davantage son équipe de direction en nommant Donald Courtney au poste de directeur principal [...]
RavenQuest BioMed Expands Into Europe
22/05/2019
VANCOUVER, British Columbia, May 22, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT1) (the “ Company ” or “ RavenQuest ”) is pleased to announce that it has signed a Heads of [...]
Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants
22/05/2019
Valby, Denmark, 22 May 2019 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 130,490 as a consequence of the exercise of employee warrants. The increase is effected [...]
Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients
22/05/2019
Late-Breaking Clinical Trial Results and Updated Global SYMPLICITY Registry Data Demonstrate Long-Term Results of RDN for Uncontrolled Hypertension DUBLIN and PARIS - May 22, 2019 - Investigators today unveiled late- [...]
Nexstim sells first NBT® system in Germany for depression therapy and research
22/05/2019
Press release, Helsinki, 22 May 2019 at 11.30 am (EET) Nexstim sells first NBT ® system in Germany for depression therapy and research Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing [...]
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
22/05/2019
COPENHAGEN, Denmark, May 22, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initiation of a new share buy-back program, under which the Company intends to buy back up to 28,849 of its own shares [...]
Centauri's AlphamerTM Platform highlighted at 4th Annual Advances in Immuno-Oncology Congress
22/05/2019
Centauri's Alphamer TM Platform highlighted at 4th Annual Advances in Immuno-Oncology Congress UK, 22 May 2019: Centauri Therapeutics (“Centauri”), an immunotherapy company active in oncology and infectious diseases, [...]
Motif Bio to Evaluate Orphan Disease Opportunity for Iclaprim in Ophthalmology
22/05/2019
NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has signed an [...]
Bavarian Nordic Announces Interim Results for the First Three Months of 2019
22/05/2019
COPENHAGEN, Denmark, May 22, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first three months of 2019. Paul Chaplin, President & Chief [...]

Pages